نتایج جستجو برای: intravitreal triamcinolone acetonide

تعداد نتایج: 9096  

Journal: :Archives of ophthalmology 2008
Olcay Tatar Kei Shinoda Edwin Kaiserling Grazia Pertile Claus Eckardt Andreas Mohr Efdal Yoeruek Peter Szurman Karl U Bartz-Schmidt Salvatore Grisanti

OBJECTIVE To evaluate the early effects of triamcinolone acetonide as monotherapy or as an adjuvant to ocular verteporfin photodynamic therapy (PDT) on angiogenesis in human choroidal neovascularization (CNV) secondary to age-related macular degeneration. METHODS Retrospective review of an interventional series of 55 patients who underwent CNV extraction. Eleven patients were treated with int...

Journal: :Archives of ophthalmology 2004
Ziad F Bashshur Riad N Ma'luf Souha Allam Fadi A Jurdi Randa S Haddad Baha' N Noureddin

OBJECTIVE To evaluate the efficacy of intravitreal triamcinolone acetonide in the management of persistent macular edema secondary to nonischemic central retinal vein occlusion (CRVO). METHODS Twenty consecutive patients were selected with a 3- to 4-month history of nonischemic CRVO and persistent macular edema. These patients received a single intravitreal injection of 4 mg of triamcinolone ...

Journal: :بینا 0
زهرا ربانی خواه z rabbanikhah تهران- پاسداران- خیابان امیر ابراهیمی- نبش بوستان نهم- پلاک 5- مرکز تحقیقات چشم ویکتوریا کیاوش v kiarash علیرضا رمضانی ar ramezani تهران- پاسداران- خیابان امیر ابراهیمی- نبش بوستان نهم- پلاک 5- مرکز تحقیقات چشم مهدی یاسری m yaseri تهران- پاسداران- خیابان امیر ابراهیمی- نبش بوستان نهم- پلاک 5- مرکز تحقیقات چشم مسعود سهیلیان m soheilian تهران- پاسداران- خیابان امیر ابراهیمی- نبش بوستان نهم- پلاک 5- مرکز تحقیقات چشم

purpose: to compare intravitreal bevacizumab (ivb) with intravitreal triamcinolone acetonide (ivt) for treatment of refractory uveitic cystoid macular edema (cme). methods: in this randomized clinical trial, 31 eyes with uveitic cme were allocated into 2 groups: the ivb group, received one to three injections of 1.25 mg bevacizumab (15 eyes); the ivt group received one to three injections of 2m...

الماسی حشیانی, امیر, خسروی, احمد, رشیدی, عبدالله, رضایی, رضا, واعظ, سیدمرتضی,

Background and Objective: Macular edema is an important cause of visual loss in diabetic patients which can lead to permanent vision loss in untreated cases. This study compares the efficacy of intravitreal injection and the sub-tenon capsule of triamcinolone on the visual acuity in patients with diabetic retinopathy. Materials and methods: In this randomized clinical trial study, 82 diabeti...

2014
Ludo IF Penning Rob A de Bie Geert HIM Walenkamp

BACKGROUND Subacromial impingement is a common cause of shoulder complaints in general practice. When the initial treatment with acetaminophen and low dose Non Steroidal Anti Inflammatory Drugs fails, triamcinolone acetonide injections are commonly used. Triamcinolone acetonide injections are effective at four to six weeks. Little is known about the pain relief effect of triamcinolone acetonide...

2012
Paolo Lanzetta

Diabetic macular oedema is a major cause of severe visual loss whose pathogenesis appears to be complex and multifactorial. For many years laser photocoagulation has been the standard of care for the treatment of this condition. Emerging pharmacologic approaches are being evaluated through randomised controlled trials. Triamcinolone acetonide has been proposed as a promising option, due to its ...

Journal: :Investigative ophthalmology & visual science 2006
Raja Narayanan Jeanie K Mungcal M Cristina Kenney Gail M Seigel Baruch D Kuppermann

PURPOSE To study the toxicity of triamcinolone acetonide (Kenalog; Bristol-Meyers Squibb, Princeton, NJ) on retinal pigment epithelial (ARPE-19) and retinal neurosensory (R28) cells. METHODS ARPE-19 and R28 were grown in tissue culture in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum. Cells were treated with 50, 100, and 200 microg/mL concentration of triamcinolo...

2009
Dimitrios Brouzas Chryssanthi Koutsandrea Marilita Moschos Spiros Papadimitriou Ioannis Ladas Michael Apostolopoulos

PURPOSE To report a severe ocular complication initiated ten days after intravitreal administration of bevacizumab (Avastin((R))), in a patient with exudative age-related macular degeneration (AMD). PATIENTS AND METHOD Case report. RESULTS Ten days after intravitreal injection of 1.25 mg Avastin((R)), the patient manifested acute loss of vision with excruciating pain. An extensive choroidal...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید